Genentech, a pioneering biotechnology leader, develops innovative medicines to transform patients’ lives. Founded in 1976, it remains at the forefront of scientific research and healthcare advancements.
Drugmaker Gilead Sciences announced an $11 billion investment to expand its U.S. manufacturing capabilities, aiming to boost production capacity and job growth, the San Francisco Business Times reports.